上海证券近日发布机械行业周报：BEST项目重要部件相继交付，行业迎密集招投标 期。产业端，根据可控核聚变公众号，由中国科学院等离子体物理研究所主导设计，聚变新 能承建的紧凑型聚变能实验装置（BEST）迎来重要部件集中交付。10月1日，BEST项目主 机系统中杜瓦底座研制成功并顺利完成交付，精准落位安装在BEST装置主机大厅内。 以下为研究报告摘要： 主要观点 过去一周2个交易日（2025.10.9-2025.10.10），中信机械行业下跌0.62%，表现处于中下 游，在所有一级行业中涨跌幅排名第21。可控核聚变：BEST项目重要部件相继交付，行业 迎密集招投标期。产业端，根据可控核聚变公众号，由中国科学院等离子体物理研究所主导 设计，聚变新能承建的紧凑型聚变能实验装置（BEST）迎来重要部件集中交付。10月1日， BEST项目主机系统中杜瓦底座研制成功并顺利完成交付，精准落位安装在BEST装置主机大 厅内。杜瓦底座是BEST装置主机的首个真空大部件，设计工况复杂，接口数达百余个，是 主机系统中的最重部件、也是国内聚变领域最大的真空部件，该部件落位安装标志着BEST 项目主体工程建设步入新阶段，部件研制和工程安 ...

Investment Rating - The report maintains an "Overweight" rating for the machinery equipment industry [1] Core Views - The machinery equipment sector is currently experiencing a mixed performance, with a recent decline of 0.62% in the CITIC machinery industry index, ranking 21st among all primary industries [4][17] - The report highlights significant developments in various sub-sectors, including controlled nuclear fusion, semiconductor equipment, and humanoid robots, indicating potential investment opportunities [5][6][7] Summary by Sections 1. Market Review - The CITIC machinery industry index fell by 0.59% over two trading days, underperforming compared to the broader market indices [17] - Specific sub-sectors showed varied performance, with engineering machinery down by 1.17% and transportation equipment up by 1.67% [18] 2. Industry High-Frequency Data Tracking - Engineering machinery PMI for September 2025 is at 49.8%, a month-on-month increase of 0.4 percentage points [23] - Forklift sales in August 2025 reached 118,000 units, a year-on-year increase of 19.4% [24] - Excavator sales in August 2025 totaled 17,000 units, up 12.8% year-on-year [24] 3. Semiconductor Equipment - Global semiconductor sales in August 2025 were $64.88 billion, a year-on-year increase of 21.7% [46] - China's semiconductor sales reached $17.63 billion, up 12.4% year-on-year [46] 4. Humanoid Robots - The report discusses the launch of Figure 03, a third-generation humanoid robot, which features significant advancements in perception and decision-making capabilities [7][8] 5. Investment Recommendations - Suggested companies for investment include: 1. Engineering Machinery: SANY Heavy Industry, Zoomlion, XCMG, Liugong, and Hengli Hydraulic [9] 2. Semiconductor Equipment: North Huachuang, Zhongwei Company, and Jinchuan Technology [9] 3. Humanoid Robots: Focus on high-tech components with low domestic production rates [9]

Core Viewpoint - Fostar (603173.SH) is making a significant investment of approximately 1 billion yuan in the marine engineering and equipment intelligent manufacturing project, aiming to extend its industrial chain and enhance its product structure towards high value-added offerings [1][2]. Investment Project Details - The project will be located in the Qidong Lusi Port Economic Development Zone, covering a total area of about 505 acres, including 240 acres of industrial land and 265 acres of industrial sea area [1]. - The project will produce large marine engineering equipment, oil and gas modules, and large chemical containers, supported by a heavy-duty terminal to facilitate the manufacturing and delivery of large equipment [1][2]. - A wholly-owned subsidiary will be established to manage the investment, construction, and operations of the project, with a registered capital of no less than 588 million yuan [1]. Strategic Goals - The investment aims to optimize the product structure towards high value-added products and accelerate the company's transformation towards large-scale, high-end, engineering, and service-oriented operations [2]. - The heavy-duty terminal is a key infrastructure that will enhance the company's delivery capabilities for large and oversized projects, improving customer loyalty and export advantages [2]. Financial Performance - Fostar has shown robust financial performance since its listing in January 2023, with revenues of 2.156 billion yuan, 2.419 billion yuan, and 1.476 billion yuan for 2023, 2024, and the first half of 2025, reflecting year-on-year growth of 14.3%, 12.2%, and 62.14% respectively [2][3]. - The net profit attributable to shareholders for the same periods was 191 million yuan, 261 million yuan, and 251 million yuan, with year-on-year growth rates of 34.67%, 36.63%, and 140.45% respectively [2][3]. Order and Market Performance - As of the first half of 2025, Fostar reported a contract liability of 1.975 billion yuan, an increase of 41.39% year-on-year, indicating a stable operational situation and strong investor interest [4]. - The stock price of Fostar reached 51.6 yuan per share as of October 14, 2025, reflecting a cumulative increase of 128.82% since the beginning of 2025 [4].

Group 1: Trade and Economic Indicators - In the first three quarters of this year, China's goods trade import and export reached 33.61 trillion yuan, a year-on-year increase of 4% [3] - Exports amounted to 19.95 trillion yuan, growing by 7.1% year-on-year, while imports were 13.66 trillion yuan, showing a slight decline of 0.2% [3] - In September, the total goods trade import and export was 4.04 trillion yuan, reflecting a year-on-year growth of 8% [3] Group 2: Company Performance and Forecasts - Chujiang New Materials expects a net profit of 350 million to 380 million yuan for the first three quarters, representing a year-on-year increase of 2057.62% to 2242.56% [5] - Morning Light Bio anticipates a net profit of 278 million to 314 million yuan, with a year-on-year growth of 344.05% to 401.55% [5] - Sanmei Co. forecasts a net profit of 1.524 billion to 1.646 billion yuan, indicating a year-on-year increase of 171.73% to 193.46% [5] - Shengnuo Bio expects a net profit of 114 million to 140 million yuan, reflecting a year-on-year growth of 100.53% to 145.10% [5] - Feirongda anticipates a net profit of 275 million to 300 million yuan, with a year-on-year increase of 110.80% to 129.96% [5] - Juxin Technology expects a net profit of 151 million yuan, a year-on-year increase of 112.94% [6] Group 3: Share Buybacks and Corporate Actions - COSCO Shipping Holdings plans to repurchase 50 million to 100 million A-shares, with an estimated repurchase amount of 749 million to 1.498 billion yuan [6] - Ji'an Medical intends to repurchase shares worth 300 million to 600 million yuan [7] - Luyin Investment's controlling shareholder plans to increase holdings of company shares by 40 million to 80 million yuan [7] - Yiyi Co. is planning to issue shares and pay cash to acquire assets, specifically targeting Hangzhou Gao Ye Jia You Duo Mao Pet Food Co., Ltd. [7] - Everbright Bank announced a comprehensive credit limit of 29 billion yuan for China CITIC Financial Asset Management Co., Ltd. [7] Group 4: Regulatory and Market Developments - The Chongqing Municipal Government has issued a three-year action plan for urban renewal from 2025 to 2027, aiming for significant progress and the establishment of a new investment mechanism [4] - Hangzhou's government is working on regulations to promote the development of intelligent robotics, aiming to create a globally competitive AI innovation hub [4] - The 2025 Financial Street Forum will be held in Beijing from October 27 to 30, focusing on global financial development under innovation and transformation [3]

Group 1: Company Announcements - Hezhong Intelligent (合锻智能) reported no revenue from nuclear fusion-related business [1] - Fostar (福斯达) plans to invest approximately 1 billion yuan in the construction of a marine engineering and equipment intelligent manufacturing project [1] - Zhongyan Dadi (中岩大地) won a contract for a 770 million yuan engineering project [1] - Meili Technology (美力科技) intends to acquire 10.1% equity in Beijing Dayuan and Jiangsu Dayuan [1] - Jiuan Medical (九安医疗) plans to repurchase shares worth 300 million to 600 million yuan [1] - Sanmei Co., Ltd. (三美股份) expects a net profit increase of 171.73% to 193.46% year-on-year for the first three quarters [1] - Chen Yategong (陈亚特工) plans to reduce holdings by 2.99% [1] - Asia-Pacific Pharmaceutical (亚太药业) intends to raise no more than 700 million yuan through a private placement to Xinghao Holdings [1] - Feiliwa (非利华) plans to raise no more than 300 million yuan through a private placement [2] Group 2: Investment Projects - New Asia Cable (新亚电缆) plans to invest 298 million yuan in a green and environmentally friendly cable industry project [1] - Fostar (福斯达) is set to invest about 1 billion yuan in a marine engineering and equipment intelligent manufacturing project [1] Group 3: Share Buybacks - China Merchants Industry Holdings (中远海控) plans to repurchase 50 million to 100 million A-shares [2] - Jiuan Medical (九安医疗) intends to repurchase shares worth 300 million to 600 million yuan [2] - China National Machinery Industry Corporation (中工国际) plans to repurchase shares worth 50 million to 100 million yuan [2] - Fujilai (富士莱) plans to repurchase shares worth 20 million to 40 million yuan [2] - Obizhongguang (奥比中光) plans to repurchase shares worth 25 million to 50 million yuan [2] Group 4: Performance Forecasts - Sanmei Co., Ltd. (三美股份) expects a net profit increase of 171.73% to 193.46% year-on-year for the first three quarters [2] - Yuegui Co., Ltd. (粤桂股份) anticipates a net profit increase of 86.87% to 109.11% year-on-year for the first three quarters [2] - Salt Lake Co., Ltd. (盐湖股份) expects a net profit increase of 36.89% to 49.62% year-on-year for the first three quarters [2] - Shengnuo Biotechnology (圣诺生物) anticipates a net profit increase of 100.53% to 145.1% year-on-year for the first three quarters [2] Group 5: Equity Transfers - Yonghe Zhikong (永和智控) plans to transfer 51% equity and debt of Taixing Puluo [1] - Meizhi Co., Ltd. (美芝股份) plans to transfer 51% equity of Yingju Construction [1] - Meili Technology (美力科技) intends to acquire 10.1% equity in Beijing Dayuan and Jiangsu Dayuan [1] - Kangwei Century (康为世纪) plans to acquire 49% equity of its subsidiary Haowei Tai [1]

| | | 10月13日重要公告精选 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 热点 | 合俄智能 | 未取得核聚变相关业务收入 | | 签约项目 | 福斯达 | 拟约10亿元建设福斯达海洋工程与装备智能制造项目 | | 合同中标 | 中岩大地 | 中标7.7亿元工程项目 | | 股权转让 | 美力科技 | 拟收购北京大圆及江苏大圆各10.1%股权 | | 回购 | 九安医疗 | 拟回购3亿元-6亿元公司股份 | | 业绩预告 | 三美股份 | 前三季度净利润同比预增171. 73%到193. 46% | | 增减持 | 腾亚精工 | 实际控制人之一致行动人拟减持2.99%股份 | | 其他 | 亚太药业 | 拟向星浩控股定增募资不超过7亿元 | | | 菲利华 | 拟定增募资不超过3亿元 号筒隆汇 | 【热点 】 合锻智能(603011.SH)：未取得核聚变相关业务收入 【 项 目 投资】 新亚电缆(001382.SZ)：拟2.98亿元投资建设绿色环保电缆产业项目 福斯达(603173.SH)： 拟投资约10亿元建设福斯达海洋工程与装备智能制造项目 中远海控(60 ...

Group 1: Financial Performance - Xinhua Insurance expects a net profit of 29.986 billion to 34.122 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 45% to 65% due to reforms and improved investment returns [2] - Feirongda anticipates a net profit of 275 million to 300 million yuan for the first three quarters of 2025, reflecting a growth of 110.80% to 129.96% driven by increased R&D in AI and cooling technologies [2] - Lingyi Zhizao forecasts a net profit of 1.890 billion to 2.120 billion yuan for the first three quarters of 2025, marking a growth of 34.10% to 50.42% attributed to new product launches and increased overseas revenue [5] - Yilake Co. expects a net profit of 4.300 billion to 4.700 billion yuan for the first three quarters of 2025, with a significant increase of 36.89% to 49.62% driven by rising potassium chloride prices [6] - Bojun Technology projects a net profit increase of 50% to 80% for the first three quarters of 2025 [9] Group 2: Regulatory and Corporate Actions - Fudan Zhangjiang's application for the drug Obeticholic Acid for primary biliary cholangitis was not approved by the National Medical Products Administration, with a total R&D investment of approximately 125 million yuan [3] - Northern Rare Earth received a warning letter from the Inner Mongolia Securities Regulatory Bureau for failing to disclose non-operating fund occupation by an affiliate, totaling 8.9485 million yuan [7] - Tianji Co. announced that its major shareholders reduced their holdings by 2.9996% and have terminated their reduction plan ahead of schedule [8] Group 3: Market Trends and Developments - The demand for AI server cooling solutions and related materials has increased, contributing to Feirongda's revenue growth [2] - The overall market for potassium chloride has seen price increases, positively impacting Yilake Co.'s profitability [6] - The consumer electronics market is recovering, leading to increased demand for thermal management materials, benefiting Feirongda's market share [2]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have announced significant developments, including acquisitions, regulatory warnings, and financial performance forecasts, which may present investment opportunities and risks for investors [3]. Group 1: Company Announcements - Yiyi Co. is planning to acquire a pet food company, with stock trading suspended from October 14, 2025, and a transaction proposal expected within 10 trading days [4]. - Northern Rare Earth received a warning letter from the Inner Mongolia Securities Regulatory Bureau for failing to disclose related party non-operating fund occupation amounting to 8.9485 million yuan [5][6]. - Baiyin Nonferrous Metals announced a significant stock price increase of 40.10% over four trading days, indicating potential trading risks [7]. - Huan Zhuang Intelligent has not generated any revenue from the highly discussed nuclear fusion concept, despite market interest [8]. - Guangdong Mingzhu disclosed a 1.17% reduction in total share capital by a major shareholder, amounting to 44.801 million yuan [9]. - Fudan Zhangjiang's application for the drug Obechol acid for primary biliary cholangitis was not approved, with a total R&D investment of approximately 125 million yuan [10]. - Haka Air Conditioning plans to publicly transfer 40% of its subsidiary Fushan Chuan's equity [12]. - FSD plans to invest approximately 1 billion yuan in a marine engineering and equipment intelligent manufacturing project [13]. - Everbright Bank intends to grant a comprehensive credit limit of 29 billion yuan to CITIC Financial Asset Management [14]. - Zhucheng Technology received a cash dividend of 15 million yuan from its subsidiary, which will increase its net profit for the parent company in 2025 [15]. - Haige Communication's subsidiary Tian Teng Industry is preparing for a public capital increase to attract strategic investors [16]. Group 2: Financial Performance Forecasts - Chuangjiang New Materials expects a net profit increase of 2058%-2243% for the first three quarters of 2025, projecting 350 million to 380 million yuan [17]. - Lingyi Technology anticipates a net profit growth of 34.1%-50.42%, estimating 1.89 billion to 2.12 billion yuan for the same period [18]. - Salt Lake Co. forecasts a net profit increase of 97%-141% for the third quarter, with an estimated profit of 1.8 billion to 2.2 billion yuan [20]. - Feirongda expects a net profit increase of 111%-130%, projecting 275 million to 300 million yuan for the first three quarters [21]. - New China Life Insurance anticipates a net profit increase of 45%-65%, estimating 29.986 billion to 34.122 billion yuan for the first three quarters [22]. - Zhongtong Bus reported a 36.88% year-on-year increase in sales for September, totaling 1,106 units [23]. Group 3: Shareholding Changes - Yuntian Lihui's shareholders reduced their holdings by 3.1702 million shares, decreasing their stake from 7.8697% to 6.9862% [24]. Group 4: Financing Activities - Filihua plans to raise no more than 300 million yuan through a private placement for the construction of a quartz electronic yarn intelligent manufacturing project [25]. Group 5: Major Contracts - Han Jian Heshan won a bid for a 207 million yuan land drainage project, representing 26.29% of its audited revenue for 2024 [26][27]. - *ST Weihai is a candidate for a 313 million yuan engineering project, which would account for 12.60% of its audited total revenue for 2024 [28].

Core Viewpoint - The company, Fostar, plans to invest approximately 1 billion RMB in the construction of an intelligent manufacturing project for marine engineering and equipment, aiming to enhance its competitive edge in high-end equipment manufacturing and extend the application of cryogenic technology [1][3]. Group 1: Investment Details - Fostar has signed an investment agreement with the Qidong Municipal Government to develop the "Fostar Marine Engineering and Equipment Intelligent Manufacturing Project" in the Qidong Lusi Port Economic Development Zone, with a total investment of around 1 billion RMB [1]. - The project will cover a total area of approximately 505 acres, including 240 acres of industrial land and 265 acres of industrial sea area, with a coastline usage of about 380 meters [1]. - A wholly-owned subsidiary will be established to manage the investment, construction, and operation of the project, with a registered capital of no less than 588 million RMB [2]. Group 2: Strategic Importance - The application of cryogenic technology in marine engineering is becoming increasingly critical, particularly in the transportation and processing of liquefied natural gas (LNG) [3]. - The project aims to capture market opportunities in high-value marine equipment manufacturing, thereby expanding the company's product application areas and creating new growth points [3]. - The construction of a heavy-duty terminal as part of the project will enhance the company's delivery capabilities for large equipment, improving customer retention and export advantages in the large and super-large equipment sectors [3].

Company Announcements - Northern Rare Earth received a warning letter from the Inner Mongolia Securities Regulatory Bureau due to undisclosed non-operating fund occupation by related parties, amounting to 8.9485 million yuan, which has been fully repaid [2] - Aosheng Electronics reported that revenue from controllable nuclear fusion-related products will account for less than 1% of its main business revenue in the first half of 2025 [2] - Yiyi Co. is planning to acquire a pet food company, leading to a stock suspension [3] - Sanmei Co. expects a net profit increase of 172%-193% year-on-year for the first three quarters, driven by a significant rise in the average price of fluorinated refrigerants [4] - Feirongda anticipates a net profit increase of 111%-130% year-on-year for the first three quarters, with growth in AI server cooling-related business revenue [4] - Zhongshi Technology expects a net profit increase of 74%-104% year-on-year for the first three quarters, benefiting from increased shipments of thermal materials and components [4] - Juxin Technology forecasts a net profit increase of 113% year-on-year for the first three quarters, with sales revenue from edge AI processor chips increasing significantly [4] - Chuangjiang New Materials expects a staggering net profit increase of 2058%-2243% year-on-year for the first three quarters [4] - New China Life Insurance anticipates a net profit increase of 45%-65% year-on-year for the first three quarters [4] Investment & Contracts - Fostda plans to invest 1 billion yuan in the construction of an intelligent manufacturing project for marine engineering and equipment [11] Shareholding Changes - Dongxin Co. has set an initial transfer price of 82.5 yuan per share for its inquiry transfer, which is a 16% discount from the closing price [11] - China Jushi has obtained a commitment letter for a stock repurchase loan of up to 630 million yuan [12] - Tianji Co. has reduced its holdings by 2.9996% of the company's shares and has terminated its reduction plan early [3] Performance & Operations - Yingweike reported a net profit of 183 million yuan for the third quarter, an increase of 8.35% year-on-year [13] - Chenguang Biological expects a net profit increase of 344%-402% year-on-year for the first three quarters [14] - Meili Ecology's subsidiary won a bid for a 2.375 billion yuan urban renewal project in Shenzhen [18] Stock Price Movements - Hezhu Intelligent has not generated any revenue related to nuclear fusion concepts [19] - Jinli Yongci confirmed that its recent stock price fluctuations are not due to undisclosed significant matters [20] Other Developments - Heng Rui Medicine's subsidiary received approval for clinical trials of SHR-1905 injection [24] - Renfu Medicine received a drug registration certificate for Dapoxetine Hydrochloride Tablets, which are expected to generate approximately 1.1 billion yuan in sales in 2024 [26]